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Fractionated Stereotactic Radiosurgery
Alone for the Treatment of a Papillary
Craniopharygioma
Tyler J. Kenning, MD; James J. Evans, MD
Neurosurgery Department, Thomas Jefferson University, Philadelphia, Pennsylvania

Abstract
The use of radiation treatment (RT) is usually
reserved for residual or recurrent craniopharyngiomas, and the role of RT alone and not as
an adjunctive therapy to surgery has not been
clearly defined. The authors describe a case
of a 50-year-old man presenting with a large
suprasellar craniopharyngioma with extension into the third ventricle, producing acute
hydrocephalus. A ventriculoperitoneal shunt
was performed concurrently with an endoscopic
biopsy. Treatment with fractionated stereotactic
radiosurgery (FSR) resulted in near resolution of
the lesion with no evidence of recurrence over
six years. A review of RT for the treatment of
craniopharyngiomas without surgical resection
is performed.

Introduction

A

C

B

D

Figure 1
Cranial CT upon initial presentation, demonstrating an isodense third ventricular mass with
lateral ventricular dilatation
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Craniopharyngiomas are histologically benign
extraaxial epithelial tumors that arise form
embryologic remnants of Rathke’s pouch.12
These rare lesions have an estimated incidence
of 1.5 per million people per year, but comprise
10-15% of all pediatric brain tumors.7,21 Despite
their benign histology, craniopharyngiomas
cause significant morbidity from damage to the
hypothalamus, optic apparatus, and endocrine
system. Aggressive treatment is advocated, but
the optimal treatment is often debated.
Radical resection is often utilized as a first line
treatment due to the frequently large size of
these lesions at presentation and associated
mass effect.6,24 Such surgery, however, can carry
a high risk of morbidity with hypothalamic and
endocrine dysfunction.26 For this reason, many
favor subtotal resection with preservation of
adjacent anatomical structures and adjuvant
therapies for residual tumor.11,18 The use of
radiotherapy in isolation for the treatment of
craniopharyngiomas is infrequent.

Case Report
A 50-year-old man suffering from two months
of headache and neck pain presented to the
emergency department with a dramatic deterioration of his vision, limb paresis, and seizures.
Cranial imaging demonstrated a 3.7 x 2.5 X 3.2
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Figure 2
(A) Coronal and (B) sagittal cranial T1WI MRI with gadolinium showing an enhancing suprasellar mass consistent with craniopharyngioma

cm, solid suprasellar mass with extension into
the third ventricle, producing acute hydrocephalus (Figures 1 and 2). Through a right
frontal burrhole, placement of a ventriculoperitoneal shunt was performed concurrently with
an endoscopic biopsy of the third ventricular
mass tumor (Figure 3). Intraoperatively, a
yellow-colored frond-like mass with a consistency similar to choroid plexus was seen filling
the right foramen of Monro. Pathology was
consistent with a papillary craniopharyngioma.

largely based on the results of open approaches,
the role of endoscopic endonasal resection in
limiting that morbidity is unclear (Figure 5).

Discussion

Radiotherapy is most often used as an adjunctive treatment for craniopharyngiomas, either
in the setting of residual tumor after a subtotal
resection or for tumor recurrence. Published
series report a local control rate of 79-95% in
these patients.2,13,14,18,19,22,23 In a review of their
craniopharyngioma patients with long-term
follow-up, Karavitaki et al. divided 121 patients
into four groups: 1) GTR, 2) GTR plus RT, 3)
sub-total resection (STR), and 4) STR plus RT.
In this cohort, the ten year recurrence-free
survival rates were 100%, 100%, 38%, and 77%,
respectively.11 These results have been reproduced in the literature examining the newer
techniques of fractionated radiation therapy.
Typically, 45-55 Gy in 1.8-2.0 Gy fractions
are utilized and ten year local control rates for
surgery with postoperative FSR are 57-89%
compared to 31-42% with surgery alone.25

The treatment of craniopharyngiomas is highly
controversial. This controversy is further fueled
by the myriad therapeutic modalities available:
cystic drainage, intracavitary chemotherapy,
limited resection or gross total resection (GTR),
and radiation therapy. The greatest debate exists
between those favoring radical surgical excision
and those believing that subtotal resection followed by adjuvant therapy is best to spare the
potential morbidity associated with aggressive
surgery. While criticisms of surgical treatment are

The effect of radiotherapy for craniopharyngiomas appears to be affected by the consistency of
the lesion with more solid tumors having the
highest average control rate of 90%. Tumors that
are either cystic or mixed have rates of 88% and
60%, respectively.25 The impact of histology on
radiation effect is somewhat less clear. While
some groups have not found a significant difference between adamantinomatous and papillary
craniopharyngiomas, Inoue et al. did find a better
response in the latter.4,10,15

The patient was subsequently treated with
fractionated stereotactic radiosurgery (FSR)
for a total of 54 Gy to the 88% isodose line in
thirty 1.8 Gy fractions. Within a month of FSR
completion, the tumor volume was reduced by
nearly half and continued to diminish on each
following imaging study. With six years of
follow-up, the lesion continues to demonstrate
near resolution with no recurrence and further
treatment has not been necessary (Figure 4).
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Figure 3
Cranial CT following ventriculoperitoneal
shunt placement and endoscopic biopsy

Most reports on radiotherapy discuss craniopharyngioma stability and local tumor control.
Few studies describe the effect on tumor size.
Significant lesion reduction has been documented after fractionated external radiation3,8
and stereotactic radiosurgery.27 In our reported
patient, we observed significant tumor shrinkage within one month and this effect has been
sustained currently for six years, demonstrating
FSR as a possible alternative for initial therapy in
select cases. Despite this result, we continue to
utilize and recommend surgery as the first line
treatment for craniopharyngiomas. We reserve
FSR for patients with a significant residual tumor
residual or with recurrence. Despite its appeal as a
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Conclusions
While surgery remains the initial treatment of
choice for craniopharyngiomas, the debate
between GTR versus STR and even open versus
endoscopic endonasal approaches continues to
persist. Radiotherapy is often reserved for residual or recurrent disease, but we have been able to
show that, when necessary, FSR can be effective
as an initial treatment. After establishment of a
tissue diagnosis, solid papillary craniopharyngiomas may be the most suitable for radiotherapy if
surgical resection is not feasible.

A

B

19. Minniti G, Saran F, Traish D, et al. Fractionated stereotactic
conformal radiotherapy following conservative surgery in
the control of craniopharyngiomas. Radiother Oncol 82:
90-5, 2007
20. Movsas B, Movsas TZ, Steinberg SM, Okunieff P. Long-term
visual changes following pituitary irradiation. Int J Radiat
Oncol Biol Phys 33: 599-605, 1995
21. Rickert CH, Paulus W. Epidemiology of central nervous
system tumors in childhood and adolescence based on the
new WHO classification. Childs Nerv Syst 17: 503-11, 2001
22. Schulz-Ertner D, Frank C, Herfarth K, et al. Fractionated
stereotactic radiotherapy for craniopharyngiomas. Int J Radiat
Oncol Biol Phys 54: 1114-20, 2002

References
1. Agha A, Sherlock M, Brennan S, O’Connor SA, O’Sullivan
E, Rogers B, et al. Hypothalamic-pituitary dysfunction after
irradiation of nonpituitary brain tumors in adults. J Clin
Endocrinol Metab 90: 6355-6360
2. Cabezudo Artero JM, Vaquero Crespo J, Bravo Zabalgoitia G.
Status of vision following surgical treatment of craniopharyngiomas. Acta Neurochir 73: 165-77, 1984

18. Merchant TE, Kiehna EN, Sanford RA, et al.
Craniopharyngioma: the St. Jude Children’s Research
Hospital experience 1984-2001. Int J Radiat Oncol Biol Phys
53: 533-42, 2002

23. Smee RI, Williams JR, Kwok, B, Teo C, Stening W. Modern
radiotherapy approaches in the management of craniopharyngiomas. J Clin Neurosci 18: 613-7, 2011

C

D

24. Van Effenterre R, Boch AL. Craniopharyngiomas in adults
and children: a study of 122 surgical cases. J Neurosurg 97:
3-11, 2002
25. Veeravagu A, Lee M, Jiang B, Chang SD. The role of radiosurgery in the treatment of craniopharyngiomas. Neurosurg
Focus 28: E11, 2010

3. Constine LS, Randall SH, Rubin P, McDonald J.
Craniopharyngiomas: fluctuation in cyst size following
surgery and radiation therapy. Neurosurgery 24: 53-9, 1989

26. Yasargil MG, Curcic M, Kis M, Siegenthaler G, Teddy PJ, Roth
P. Total removal of craniopharyngiomas: approaches and
long-term results in 144 patients. J Neurosurg 73: 3-11, 1990

4. Crotty TB, Scheithauer BW, Young WF, Davis DH, Shaw
EG, Miller GM, Burger PC. Papillary craniopharyngioma:
a clinicophathological study of 48 cases. J Neurosurg 83:
206-214, 1995

27. Yomo S, Hayashi M, Chernov M, Tamura N, Izawa M, Okada
Y, et al. Stereotactic radiosurgery of residual or recurrent
cranopharyngioma: new treatment concept using Leksell
gamma knife model C with automatic positioning system.
Stereotact Funct Neurosurg 87: 360-7, 2009

5. Darzy KH, Shalet SM. Hypopituitarism after cranial irradiation. J Endocrinol Invest 28: 78-87, 2005
6. Fahlbusch R, Honegger J, Paulus W. Surgical treatment
of craniopharyngiomas: experience with 168 patients. J
Neurosurg 90: 237-50, 1999
7. Haupt R, Magnani C, Pavanello M, Caruso S, Dama E, Garre
ML. Epidemiologica aspects of craniopharyngioma. J Pediatr
Endocrinol Metab 19: 289-93, 2006
8. Honegger J, Grabenbauer GG, Paulus W, Fahlbusch R.
Regression of a large solid papillary craniopharyngioma
following fractionated external radiotherapy. J Neurooncol
41: 261-6, 1999
9. Henegger J, Tatagiba M. Craniopharyngioma surgery.
Pituitary 11: 361-373, 2008
10. Inoue HK, Nakamura M, Ono N, Kohga H, Kakegawa T,
Naitou I, Tamada J, Handa I. Radiosensitive squamous cell
craniopharyngioma: clinical and pathological comparison
with the adamantinomatous type. Brain Tumor Pathol 10:
27-31, 1993

Figure 5
Cranial T1WI MRI with gadolinium in a patient recently treated by the senior author (JJE) by
an endoscopic endonasal approach; (A) and (B) preoperative sagittal and coronal images; (C)
and (D) postoperative sagittal and coronal images following a complete resection

11. Karavitaki N, Brufani C, Warner JT, et al.
Craniopharyngiomas in children and adults: systemic analysis
of 121 cases with long-term follow-up. Clin Endocrinol 62:
397-409, 2005
12. Karavitaki N, Cudlip S, Adams CB, Wass JA.
Carniopharyngiomas. Endocr Rev 27: 371-97, 2006
13. Kobayashi T, Kida Y, Mori Y, et al. Long-term results of
gamma knife surgery for the treatment of craniopharyngioma
in 98 consecutive cases. J Neurosurg 103: 482-8, 2005

Figure 4

14. Karavitaki N, Wass JAH. Craniopharyngiomas. Endocrinol
Metab Clin North Am 37: 173-93

Sequential coronal and sagittal T1WI MRIs with gadolinium demonstrating progressive tumor
regression at 1 month, 1 year, and 6 years after radiation

15. Manaka S, Teramoto A, Takakura K. The efficacy of radiotherapy for craniopharyngioma. J Neurosurg 62: 648-656, 1985

“less invasive” treatment, radiation is not a benign
treatment. It can result in growth hormone deficit
in pediatric patients, neurocognitive impairment,
and optic neuropathy.9,17,20 Radiation effects

4

https://jdc.jefferson.edu/jhnj/vol7/iss1/1
DOI: https://doi.org/10.29046/JHNJ.007.1.005

JHN JOURNAL

to the hypothalamic-pituitary-adrenal axis may
produce diabetes insipidus, panhypopituitarism,
hypogonadism, hypothalamic obesity, and sleep
disturbance.1,5,16

16. McCollough WM, Marcus RB Jr, Rhoton AL Jr, Ballinger
WE, Million RR. Long-term follow-up of radiotherapy for
pituitary adenoma: the absence of late recurrence after greater
than or equal to 4500 cGy. Int J Radiat Oncol Biol Phys 21:
607-614, 1991
17. Merchant TE. Craniopharyngioma radiotherapy: endocrine
and cognitive effects. J Pediatr Endocrinol 19: 439-46, 2006

JHN JOURNAL

2

5

